Published Year: 2021
Global Single-Cell Multi-Omics Market (2020-2025): Focus on Product Type, Omics Type, Sample Type, T
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Inclusions and Exclusions
2.1 Research Scope
2.2 Global Single Cell RNA Sequencing Market: Research Methodology
2.3 Primary Data Sources
2.4 Secondary Data Sources
2.5 Market Estimation Model
2.6 Key Questions Answered in This Report
3.1 Market Overview
3.1.1 Introduction of Single Cell RNA Sequencing
3.1.2 Current Applications of Single Cell RNA Sequencing
3.1.3 Comparative Analysis of Single Cell RNA Sequencing Technology and Conventional RNA Sequencing Technology
3.1.4 Single Cell RNA Sequencing Market
3.2 Impact of COVID-19 on Global Single Cell RNA Sequencing Market
3.3 COVID-19 Affecting Supply Chain of Single Cell RNA Sequencing Market
3.4 Interruption in Research and Clinical Development and Commercial Operation
3.4.1 Research and Clinical Development
3.4.2 Commercial Operation and Access
3.5 Navigating Crisis Recovery and Looking to the Future
3.6 Legal Requirements and Regulations
3.6.1 Legal Requirements and Framework in the U.S.
3.6.2 Legal Requirements and Regulations in Europe
3.6.3 Legal Requirements and Framework in the Asia-Pacific
3.6.3.1 China
3.6.3.2 Japan
4.1 Market Drivers
4.1.1 Rising Applications of Single Cell RNA Sequencing in Cancer Studies and Treatment
4.1.2 Increasing Awareness and Acceptance of Personalized Diagnostics on a Global Level
4.1.3 Decreasing Cost of Sequencing
4.1.4 Increasing Government Funding for Healthcare
4.2 Business Challenges
4.2.1 Computational Challenges in Data Analysis of ScRNA Sequencing
4.2.2 High Capital Requirement
4.2.3 Lack of Infrastructure and Expertise
4.3 Business Opportunities
4.3.1 Expansion into Emerging Markets
4.3.2 Expansion into New Research Application
4.3.3 Expansion of the Product Portfolio
5.1 New Offerings
5.2 Mergers and Acquisitions
5.3 Synergistic Activities
5.4 Business Expansion and Other Strategies
5.5 Market Share Analysis, By Company
6.1 Global Single Cell RNA Sequencing Market (by Offerings) ), $ Million, 2020-2031
6.1.1 Consumables
6.1.2 Instruments
7.1 Single Cell Isolation
7.1.1 Laser Capture Microscopy (LCM)
7.1.2 Flow-Activated Cell Sorting (FACS)
7.1.3 Magnetic-Activated Cell Sorting (MACS)
7.1.4 Microfluidics
7.2 Single Cell Amplification
7.3 Library Preparation
8.1.1 Oncology
8.1.2 Immunology
8.1.3 Neurology
8.1.4 Embryology
8.1.5 Others
9.1 Research Organizations
9.2 Biopharmaceutical Companies
9.3 Others
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.2 Europe
10.2.1 U.K.
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 France
10.2.6 Rest-of-Europe
10.3 Asia-Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Rest-of-Asia-Pacific
10.4 Rest-of-the-World
11.1 Company Profiles
11.2 10x Genomics, Inc.
11.2.1 Company Overview
11.2.2 Role of 10x Genomics, Inc. in Global Single Cell RNA Sequencing Market
11.2.3 Key Competitors of the Company
11.2.4 Financials
11.2.5 Key Insights About Financial Health of the Company
11.2.6 SWOT Analysis
11.3 BGI Group
11.3.1 Company Overview
11.3.2 Role of BGI Group in the Global Single Cell RNA Sequencing Market
11.3.3 Key Competitors of the Company
11.3.4 SWOT Analysis
11.4 Bio-Rad Laboratories, Inc.
11.4.2 Company Overview
11.4.3 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell RNA Sequencing Market
11.4.4 Key Competitors of the Company
11.4.5 Financials
11.4.6 Key Insights About Financial Health of the Company
11.4.7 SWOT Analysis
11.5 Becton, Dickinson and Company (BD)
11.5.1 Company Overview
11.5.2 Role of Becton, Dickinson and Company (BD) in the Global Single Cell RNA Sequencing Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 Key Insights About Financial Health of the Company
11.5.6 SWOT Analysis
11.6 Fluidigm Corporation
11.6.1 Company Overview
11.6.2 Role of Fluidigm Corporation in the Global Single Cell RNA Sequencing Market
11.6.3 Key Competitors of the Company
11.6.4 Key Insights About Financial Health of the Company
11.6.5 SWOT Analysis
11.7 MedGenome
11.7.1 Company Overview
11.7.2 Role of MedGenome in the Global Single Cell RNA Sequencing Market
11.7.3 Key Competitors of the Company
11.7.4 SWOT Analysis
11.8 NanoString Technologies, Inc.
11.8.1 Company Overview
11.8.2 Role of NanoString Technologies, Inc. in the Global Single Cell RNA Sequencing Market
11.8.3 Key Competitors of the Company
11.8.4 Key Insights About Financial Health of the Company
11.8.5 SWOT Analysis
11.9 Pacific Biosciences of California, Inc.
11.9.1 Company Overview
11.9.2 Role of Pacific Biosciences of California, Inc. in the Global Single Cell RNA Sequencing Market
11.9.3 Key Competitors of the Company
11.9.4 Financials
11.9.5 Key Insights About Financial Health of the Company
11.9.6 SWOT Analysis
11.10 QIAGEN N.V.
11.10.1 Company Overview
11.10.2 Role of QIAGEN N.V. in the Global Single Cell RNA Sequencing Market
11.10.3 Key Competitors of the Company
11.10.4 Financials
11.10.5 Key Insights About Financial Health of the Company
11.10.6 SWOT Analysis
11.11 PerkinElmer Inc.
11.11.1 Company Overview
11.11.2 Role of PerkinElmer Inc. in the Global Single Cell RNA Sequencing Market
11.11.3 Key Competitors of the Company
11.11.4 Financials
11.11.5 Key Insights About Financial Health of the Company
11.11.6 SWOT Analysis
11.12 Takara Bio, Inc.
11.12.1 Company Overview
11.12.2 Role of Takara Bio, Inc. in the Global Single Cell RNA Sequencing Market
11.12.3 Key Competitors of the Company
11.12.4 Key Insights about Financial Health of Company
11.12.5 SWOT Analysis
11.13 Thermo Fisher Scientific Inc.
11.13.1 Company Overview
11.13.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell RNA Sequencing Market
11.13.3 Key Competitors of the Company
11.13.4 Financials
11.13.5 Key Insights About Financial Health of the Company
11.13.6 SWOT Analysis
Emerging Companies
11.14 Biomage Ltd.
11.15 Nucleome Informatics Pvt Ltd.
11.16 Scailyte
11.17 Analytical Biosciences Limited.
Table 1: Difference between Single Cell RNA Sequencing and RNA Sequencing
Table 2: Classification of Directive Groups IVDs
Table 3: Declining Cost of Genome
Figure 1: Trends in Single Cell Studies, November 2019-May 2020
Figure 2: Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 3: Impact Analysis of Market Drivers and Market Challenges
Figure 4: Share of Key Market Strategies and Developments, January 2017- January 2022
Figure 5: Global Single Cell RNA Sequencing Market (by Region), 2020 and 2031
Figure 6: Global Single Cell RNA Sequencing Market Segmentation
Figure 7: Global Single Cell RNA Sequencing Market Research Methodology
Figure 8: Primary Research
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Development History of Single Cell Sequencing
Figure 11: Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 12: Positive and Negative Impact of COVID-19 on Single Cell RNA Sequencing Market
Figure 13: Measure to Navigate Crisis Recovery
Figure 14: Global Single Cell RNA Sequencing Market Dynamics
Figure 15: Rising Number of New Cancer Cases (Comparative Analysis of the Cases in 2018 and 2020)
Figure 16: Applications of Single Cell RNA Sequencing in Analysis of Tumour Heterogeneity
Figure 17: Issues Addressed by Single Cell RNA Sequencing in Oncogenomics
Figure 18: Increasing Government Spending for Healthcare, 2017
Figure 19: Share of Key Market Strategies and Developments, January 2017- January 2022
Figure 20: Share of New Offerings (by Company), January 2017-January 2022
Figure 21: Share of Mergers and Acquisitions (by Company), January 2017-January 2022
Figure 22: Share of Synergistic Activities (by Company), January 2017-January 2022
Figure 23: Share of Business Expansion and Other Strategies (by Company), January 2017-January 2022
Figure 24: Market Share Analysis of Global Single Cell RNA Sequencing Market (by Company), 2020 and 2021
Figure 25: Global Single Cell RNA Sequencing (by Offerings), $Million, 2020 and 2031
Figure 26: Global Single Cell RNA Sequencing Consumables Market, $Million, 2020-2031
Figure 27: Global Single Cell RNA Sequencing Instruments Market, $Million, 2020-2031
Figure 28: Global Single Cell RNA Sequencing (by Workflow), $Million, 2020 and 2031
Figure 29: Global Single Cell RNA Sequencing Market (Single Cell Isolation), $ Million, 2020-2031
Figure 30: Global Single Cell RNA Sequencing Laser Capture Microscopy Market, $Million, 2020-2031
Figure 31: Global Single Cell RNA Sequencing Flow-Activated Cell Sorting Market, $ Million, 2020-2031
Figure 32: Global Single Cell RNA Sequencing Magnetic-Activated Cell Sorting Market, $Million, 2020-2031
Figure 33: Global Single Cell RNA Sequencing Microfluidics Market, $Million, 2020-2031
Figure 34: Global Single Cell RNA Sequencing Market (Single Cell Amplification), $Million, 2020-2031
Figure 35: Global Single Cell RNA Sequencing Market (Library Preparation), $Million, 2020-2031
Figure 36: Global Single Cell RNA Sequencing (by Application), $Million, 2020 and 2031
Figure 37: Global Single Cell RNA Sequencing Market (Oncology), $Million, 2020-2031
Figure 38: Global Single Cell RNA Sequencing Market (Immunology), $Million, 2020-2031
Figure 39: Global Single Cell RNA Sequencing Market (Neurology), $Million, 2020-2031
Figure 40: Global Single Cell RNA Sequencing Market (Embryology), $Million, 2020-2031
Figure 41: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031
Figure 42: Global Single Cell RNA Sequencing (by End-User Type), $Million, 2020 and 2031
Figure 43: Global Single Cell RNA Sequencing Market (Research Organizations), $Million, 2020-2031
Figure 44: Global Single Cell RNA Sequencing Market (Biopharmaceutical Companies), $Million, 2020-2031
Figure 45: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031
Figure 46: Global Single Cell RNA Sequencing Market (by Region), $Million, 2020 and 2031
Figure 47: North America Global Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 48: North America: Market Dynamics
Figure 49: U.S. Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 50: Canada Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 51: Europe Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 52: Europe: Market Dynamics
Figure 53: U.K. Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 54: Germany Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 55: Italy Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 56: Spain Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 57: France Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 58: Rest-of-Europe Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 59: Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 60: Asia-Pacific: Market Dynamics
Figure 61: Japan Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 62: China Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 63: India Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 64: South Korea Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 65: Australia Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 66: Rest-of-Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 67: Rest-of-the-World Single Cell RNA Sequencing Market, $Million, 2020-2031
Figure 68: Share of Key Companies Profiled
Figure 69: 10x Genomics, Inc.: Product Portfolio
Figure 70: 10x Genomics, Inc.: Overall Financials, $Million, 2017-2019
Figure 71: 10x Genomics, Inc.: Revenue (by Business Segment), $Million, 2017-2019
Figure 72: 10x Genomics, Inc.: Revenue (by Region), $Million, 2017-2019
Figure 73: : 10x Genomics, Inc.: R&D Expenditure, $Million, 2017-2019
Figure 74: 10x Genomics, Inc.: SWOT Analysis
Figure 75: BGI Group: Product Portfolio
Figure 76: BGI Group: SWOT Analysis
Figure 77: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 78: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020
Figure 79: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 80: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 81: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 82: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 83: Becton, Dickinson and Company (BD): Product Portfolio
Figure 84: Becton, Dickinson and Company (BD): Overall Financials, $Million, 2018-2020
Figure 85: Becton, Dickinson and Company (BD): Revenue (by Segment), $Million, 2018-2020
Figure 86: Becton, Dickinson and Company (BD): Revenue (by Region), $Million, 2018-2020
Figure 87: Becton, Dickinson and Company (BD): R&D Expenditure, $Million, 2018-2020
Figure 88: Becton, Dickinson and Company: SWOT Analysis
Figure 89: Fluidigm Corporation: Overall Financials, $Million, 2016-2018
Figure 90: Fluidigm Corporation: Revenue (by Business Segment), $Million, 2016-2018
Figure 91: Fluidigm Corporation: Revenue (by Region), $Million, 2016-2018
Figure 92: Fluidigm Corporation: R&D Expenditure, $Million, 2016-2018
Figure 93: Fluidigm Corporation: SWOT Analysis
Figure 94: MedGenome: Product Portfolio
Figure 95: MedGenome: SWOT Analysis
Figure 96: NanoString Technologies, Inc.: Overall Financials, $Million, 2016-2018
Figure 97: NanoString Technologies, Inc.: Revenue (by Business Segment), $Million, 2016-2018
Figure 98: NanoString Technologies, Inc.: Revenue (by Region), $Million, 2016-2018
Figure 99: NanoString Technologies, Inc.: R&D Expenditure, $Million, 2016-2018
Figure 100: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), $Million, 2016-2018
Figure 101: NanoString Technologies, Inc.: SWOT Analysis
Figure 102: Pacific Biosciences of California, Inc.: Product Portfolio
Figure 103: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020
Figure 104: Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 105: Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 106: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 107: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 108: QIAGEN N.V.: Product Portfolio
Figure 109: QIAGEN N.V.: Overall Financials, $Million, 2018-2020
Figure 110: QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020
Figure 111: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
Figure 112: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
Figure 113: QIAGEN N.V.: SWOT Analysis
Figure 114: PerkinElmer Inc.: Product Portfolio
Figure 115: PerkinElmer Inc.: Overall Financials, $Million, 2018-2020
Figure 116: PerkinElmer Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 117: PerkinElmer Inc.: Revenue (by Region), $Million, 2018-2020
Figure 118: PerkinElmer Inc.: R&D Expenditure, $Million, 2018-2020
Figure 119: PerkinElmer Inc.: SWOT Analysis
Figure 120: Takara Bio Inc.: Overall Financials, $Million, 2015-2017
Figure 121: Takara Bio, Inc.: Revenue (by Business Segment), $Million, 2015-2017
Figure 122: Takara Bio, Inc.: Revenue (by Region), $Million, 2017
Figure 123: Takara Bio, Inc.: R&D Expenditure, $Million, 2015-2017
Figure 124: Takara Bio Inc.: SWOT Analysis
Figure 125: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 126: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 127: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 128: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018–2020
Figure 129: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 130: Thermo Fisher Scientific Inc.: SWOT Analysis
Market Report Coverage
|
Single Cell RNA Sequencing Market |
|||
|
Base Year |
2020 |
Market Size in 2021 |
$605.9 Million |
|
Forecast Period |
2021-2031 |
Value Projection and Estimation by 2031 |
$2,931.3 Million |
|
CAGR During Forecast Period |
17.08% |
Number of Tables |
03 |
|
Number of Pages |
172 |
Number of Figures |
130 |
|
Market Segmentation |
• Workflow Type - Single Cell Isolation, Single Cell Amplification and Library Preparation • Offering Type - Consumables and Instruments • Application Type - Oncology, Neurology, Immunology, Embryology and Others • End-User Type - Research Organizations, Biopharmaceutical Companies and Others |
||
|
Regional Segmentation |
• North America - U.S., Canada • Europe - Germany, France, Italy, U.K., Spain, and Rest-of-Europe • Asia-Pacific - China, Japan, Australia, India, South-Korea and Rest-of-Asia-Pacific (RoAPAC) • Rest-of-the-World |
||
|
Market Growth Drivers |
• Rising Applications of Single Cell RNA Sequencing in Cancer Studies and Treatment • Increasing Awareness and Acceptance of Personalized Diagnostics on a Global Level • Decreasing Cost of Sequencing • Increasing Government Funding for Healthcare |
||
|
Market Challenges |
• Computational Challenges in Data Analysis of ScRNA Sequencing • High Capital Requirement • Lack of Infrastructure and Expertise |
||
|
Market Opportunities |
• Expansion into Emerging Markets • Expansion into New Research Application • Expansion of the Product Portfolio |
||
|
Key Companies Profiled |
10x Genomics, Inc., BGI Group, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company (BD), Fluidigm Corporation, MedGenome, NanoString Technologies, Inc., Pacific Biosciences of California, Inc., QIAGEN N.V., PerkinElmer Inc., Takara Bio, Inc., Thermo Fisher Scientific Inc. |
||
Key Questions Answered in this Report:
• What are the key applications of single cell RNA sequencing technology?
• What are the competitor technologies of single cell RNA sequencing technology?
• What are the major drivers, challenges, and opportunities of the global single cell RNA sequencing market?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• Who are the leading companies dominating the global single cell RNA sequencing market? What is the share of these companies in the global single cell RNA sequencing market?
• What are the regulations pertaining to the global single cell RNA sequencing market? What initiatives are implemented by different government bodies regulating the development and commercialization of single cell RNA sequencing?
• How is each segment of the global single cell RNA sequencing market expected to grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2031?
• How will the industry of global single cell RNA sequencing evolve during the forecast period 2021-2031?
• What is the market scenario for the global single cell RNA sequencing market in different regions?
• What are the key trends of different regions in the single cell RNA sequencing market? Which country would contribute to the highest sales of the single cell RNA sequencing market during the forecast period 2021-2031?
• What has been the impact of COVID-19 on the single cell RNA sequencing market?
Report Summary
Market Overview
The single cell RNA sequencing technology is developed to detect genome, transcriptome and other multi-omics of single cells. It has an advantage of analyzing single cells comprehensively that has created unprecedented opportunities for resolving the cell heterogeneity by expanding gene expression. Further, the commercial availability of next generation sequencing and increased focus on single cell analysis along with the maturing bioinformatics approaches has allowed researchers to incorporate the technology in making discoveries. The dramatic improvement within the technology has allowed it for a better usage in embryonic development, cancer biology, and immunology research.
North America represented one of the most attractive markets amongst all the markets in the world for single cell RNA sequencing in 2020. However, Europe is anticipated to gain more market shares in the coming years, which can be attributed to a large number of biotechnology based firms present in the region. Also, the demand for single cell RNA sequencing is higher in European countries. However, India is expected to be the fastest-growing nation globally, with growing affordability and awareness in the region.
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021-2031.
Within the research report, the market is segmented based on product, workflow, application, end-user and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
By tracking and analyzing the major developments witnessed in the past five years (January 2017- December 2021), the global single cell RNA sequencing market witnessed approximately 23 notable key developments. These included seven product launches, three mergers and acquisitions, nine synergistic developments (partnerships, collaborations, agreements, and business expansion activities), and four business expansion and others. Most of the companies are significantly undertaking product launches and synergistic activities activities to expand their product portfolios and trying to enter untapped markets to increase their global footprint. Therefore, product launches, enhancements, and synergistic activities constitute the dominant contributor’s strategies. The following figure depicts the share of key strategies undertaken by the leading companies in the global single cell RNA sequencing market.
Based on region, North America holds the largest share of the single cell RNA sequencing market due to standardised regulatory scenario and a large number of companies offering such single cell RNA sequencing services and products. Further, substantial investments made by biotechnology companies to improve the manufacturing facilities and advancing sequencing technologies along with the rise in per capita income in the region are also fuelling the growth of the respective market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Global Single Cell RNA Sequencing Market - A Global and Regional Analysis
Focus on Product, Workflow, End User and Application, Supply Chain, and Country-Wise Analysis - Analysis and Forecast, 2021-2031
Some Faq's
Frequently Asked Questions
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a CAGR of 17.08% during the forecast period 2021-2031.
The top market players are 10x Genomics, Inc., BGI Group, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company (BD), Fluidigm Corporation, MedGenome, NanoString Technologies, Inc., Pacific Biosciences of California, Inc., QIAGEN N.V., PerkinElmer Inc., Takara Bio, Inc., Thermo Fisher Scientific Inc.
Factors driving the growth of the single cell RNA sequencing market are rising applications of single cell RNA sequencing in cancer studies and treatment, increasing awareness and acceptance of personalized diagnostics on a global level, decreasing cost of sequencing, and increasing government funding for healthcare.
Some of the main challenges restricting the growth of the single cell RNA sequencing market are computational challenges in data analysis of ScRNA sequencing, high capital requirement, and lack of infrastructure and expertise.
The potential opportunities that are likely to boost the growth of the single cell RNA sequencing market are expansion into emerging markets, expansion into new Research application, and expansion of the product portfolio.
Similar Product
You may also like
Published Year: 2020
Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Coun
The single cell sequencing industry analysis by BIS Research projects the market to grow at a...